Əsas səhifə

Çap

Əks əlaqə

İnfo
Transfusion thresholds for guiding allogeneic red blood cell transfusion

Mündəricat

Transfusion thresholds for guiding allogeneic red blood cell transfusion

Sübutlu məlumatların xülasələri
26.03.2018 • Sonuncu dəyişiklik 26.03.2018
Editors

Transfusions with allogeneic red blood cells in anaemic patients with haemoglobin thresholds above 7 g/dL to 8 g/dL is effective in decreasing the proportion of participants exposed to red blood cell transfusion by 43% across a broad range of clinical specialities compared with a transfusion threshold of 9 g/dL to 10 g/dL, without affecting 30-day mortality or morbidity (i.e. cardiac events, stroke, pneumonia, and thromboembolism).

Comment: There were insufficient data of the safety of transfusion in certain clinical subgroups, including acute myocardial infarction, neurological injury/traumatic brain injury, stroke, thrombocytopenia, cancer, haematological malignancies, and bone marrow failure

Summary

A Cochrane review included 31 studies with a total of 12 587 subjects assessing the optimal haemoglobin threshold for the use of red blood cell (RBC) transfusions in anaemic patients (across a range of clinical specialities e.g. surgery, critical care). The restrictive transfusion threshold used a lower haemoglobin level to trigger transfusion (most commonly 7 g/dL or 8 g/dL), and the liberal transfusion threshold uses a higher haemoglobin level to trigger transfusion (most commonly 9 g/dL to 10 g/dL). Restrictive strategies reduced the risk of receiving a RBC transfusion by 43% across a broad range of clinical specialties (table ). Overall, restrictive transfusion strategies compared with liberal transfusion strategies did not increase or decrease the risk of 30-day mortality or any of the other outcomes assessed (i.e. cardiac events, myocardial infarction, stroke, thromboembolism, pneumonia, wound, or bacteraemia) (table ).

Restrictive compared with liberal transfusion protocols for guiding allogeneic red blood cell transfusion in anaemic adults and children
OutcomeRelative effect (95% CI) Assumed risk -Control - Liberal transfusion (Hb 9 g/dL to 10 g/dL)Corresponding risk - Intervention - Restrictive transfusion (Hb 7 g/dL to 8 g/dL) No of participants (studies) Quality of evidence
People receiving blood transfusions RR 0.57 (0.49 to 0.65) 841 / 1000 479 / 100012 587 (31), High
30-day mortalityRR 0.97 (0.81 to 1.16) 93 / 1000 90 / 1000 10 537 (23), Moderate
Myocardial infarction RR 1.08 (0.74 to 1.60)17 / 100019 / 10008 303 (16), High
Congestive heart failure RR 0.78 (0.45 to 1.35)36 / 100028 / 10006 257 (12), Low
Cerebrovascular accident - stroke RR 0.78 (0.53 to 1.14)17 / 100013 / 10007 343 (13), High
Rebleeding RR 0.75 (0.51 to 1.10)163 / 1000144 / 1000 3 108 (6), Low
Pneumonia RR 0.94 (0.80 to 1.11) 82 / 100076 / 10006 277 (14), High
Thromboembolism RR 0.77 (0.41 to 1.45)10 / 10008 / 1000 4 019 (10), High

Clinical comments

Note

Date of latest search: 27 May 2016

Ədəbiyyat

  1. Carson JL, Stanworth SJ, Roubinian N et al. Transfusion thresholds and other strategies for guiding allogeneic red blood cell transfusion. Cochrane Database Syst Rev 2016;(10):CD002042.